AARD - Aardvark Therapeutics, Inc.
3.55
0.040 1.127%
Share volume: 225,109
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$3.51
0.04
0.01%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2025 | 11-13-2025 | 03-23-2026 | |
| Cash flow financing | 88.875 M | 171.000 K | 274.000 K | |
| Other financing cash flows | 110.000 K | 171.000 K | 79.000 K | |
| Cash flow | -35.137 M | 13.287 M | 7.766 M | |
| Net income | -9.310 M | -16.316 M | -17.598 M | |
| Depreciation | 5.000 K | 10.000 K | 10.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -112.624 M | 29.246 M | 24.302 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 4.000 K | 0.000 | |
| Cash Change | -35.137 M | 13.287 M | 7.766 M |